Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Omni Shoreham Hotel

22 ene 2018 7:00 a.m. - 24 ene 2018 5:00 p.m.

2500 Calvert Street NW, , Washington, DC 20008 , USA

Pharmacovigilance and Risk Management Strategies Conference

Session 5: EU Updates

Session Chair(s)

Mick  Foy

Mick Foy

Director of Delivery

Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom

Hans-Georg  Eichler, MD, MSc

Hans-Georg Eichler, MD, MSc

Consulting Physician

Austrian Association of Social Security Bodies, Austria

Regulations and expectations for pharmacovigilance in the EEA continue to evolve. This session will explore recent developments related to postmarketing pharmacovigilance as well as the practice of drug safety during clinical trials. The focus will be on the evolving situation in the EEA, set in a global context.

Speaker(s)

Mick  Foy

Speaker

Mick Foy

Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom

Director of Delivery

Vicki  Edwards, RPh

Speaker

Vicki Edwards, RPh

Abbvie, United Kingdom

Vice President, Pharmacovigilance Excellence and International QPPV

Valerie E. Simmons, MD, FFPM

Speaker

Valerie E. Simmons, MD, FFPM

Eli Lilly and Company Ltd, United Kingdom

Senior Medical Fellow, Global Patient Safety

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.